Петру Панайота

Научные публикации

• Granagard administration prolongs the survival of human mesenchymal stem cells transplanted into a mouse model of multiple sclerosis
• Practical recommendations on treatment of multiple sclerosis with Cladribine: an Israeli Experts Group‏ Viewpoint
• Therapy with mesenchymal stem cell transplantation in multiple sclerosis is ready for prime time: YES
• Effects of Mesenchymal Stem Cell Transplantation on Cerebrospinal Fluid Biomarkers in Progressive Multiple Sclerosis
• Humoral and Cellular Immune Responses to SARS-CoV-2 mRNA Vaccination in Patients with Multiple Sclerosis: An Israeli Multi-Center Experience Following 3 Vaccine Doses
• Anatomical and functional visual network patterns in progressive multiple sclerosis
• A phase II clinical trial with repeated intrathecal injections of autologous mesenchymal stem cells in patients with amyotrophic lateral sclerosis
• Beneficial effects of a nano formulation of pomegranate seed oil, GranaGard, on the cognitive function of multiple sclerosis patients
• Long-Term Clinical and Immunological Effects of Repeated Mesenchymal Stem Cell Injections in Patients With Progressive Forms of Multiple Sclerosis
• Synergistic neuroprotective effects of Fingolimod and mesenchymal stem cells (MSC) in experimental autoimmune encephalomyelitis
• Beneficial effects of autologous mesenchymal stem cell transplantation in active progressive multiple sclerosis
• Conduction delays in the visual pathways of progressive multiple sclerosis patients covary with brain structure
• Neuralized mesenchymal stem cells (NMSC) exhibit phenotypical, and biological evidence of neuronal transdifferentiation and suppress EAE more effectively than unmodified MSC
• Vision and Vision-Related Measures in Progressive Multiple Sclerosis
• Immune reconstitution therapy (IRT) in multiple sclerosis: the rationale